chevron_leftBack
As of 20 June 2026, Excelsior Biopharma Inc. has a market cap of $37.49M USD, ranking #32649 globally and #1990 in Taiwan.
It ranks #2950 in the Healthcare sector, and #1018 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$37.49MUSD
1.19B TWD
Enterprise Value
$47.77MUSD
1.51B TWD
Revenue (TTM)
$28.41MUSD
898.26M TWD
EBITDA (TTM)
-$4.82MUSD
-152.62M TWD
Net Income (TTM)
-$5.79MUSD
-183.17M TWD
EBITDA Margin
-17%
Profit Margin
-20%
PS Ratio
1.3
PB Ratio
1.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Joseph Chen
open_in_new
Founded
1986
Website
excelsiorgroup.com.tw
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.6% | -0.2% | -6.1% | -8.3% | -12% | -4% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
6496
科懋生物科技股份有限公司
ISIN: TW0006496003
Shares Out.:
Shares Outstanding:
46.472M1
Shares Float:
36.351M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
25.30 TWD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Excelsior Biopharma Inc.
Excelsior Biopharma Inc. develops and sells pharmaceutical products in Taiwan, China, and internationally. It offers general pharmaceuticals; orphan drugs; antidotes; rapid test kits and reagent; consumer products under the Repavar, Om3gafort, Oral7, and Excelsior Probiotics brand names; and over the counter drugs under the Norit, Puresenna, and Tazac brand names. The company also provides specialty medicine and public health products. In addition, it is involved in importing and exporting of active pharmaceutical ingredients, food, and cosmeceuticals; development of cosmetics; research, importing and exporting of technologies; and pharmaceutical technologies transfer. The company was formerly known as Excelsior Enterprise Co., Ltd. and changed its name to Excelsior Biopharma Inc. in June 2003. Excelsior Biopharma Inc. was founded in 1986 and is headquartered in Taipei, Taiwan.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TWSE: 6446
|
$7.76B
21K%
245.34B TWD
|
48.6
|
|
TWSE: 1795
|
$1.83B
5K%
57.95B TWD
|
12.2
|
|
TPEX: 4123
|
$920.72M
2K%
29.11B TWD
|
3.4
|
|
TPEX: 6535
|
$805.08M
2K%
25.46B TWD
|
-
|
|
TPEX: 4743
|
$785.01M
2K%
24.82B TWD
|
-
|
|
TPEX: 4105
|
$581.1M
1K%
18.38B TWD
|
11.8
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
2M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
1M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
962K%
|
97.4
|
|
SIX: RO
|
$318.3B
849K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$284.64B
759K%
215.59B GBP
|
27.6
|
|
NYSE: MRK
|
$274.03B
731K%
|
15.1
|
chevron_leftBack